Using NHANES 2007–2020 data (n=17,373; age ≥40), PD cases identified by antiparkinsonian medication (n=232) had lower DI-GM scores.
This pilot study protocol explores the feasibility of a self-regulation and mental imagery program aimed at improving motor and cognitive functions